Skip to main content

Blood Diseases: Drugs

Question for Department of Health

UIN 10869, tabled on 9 October 2015

To ask the Secretary of State for Health, if NHS England will develop a clinical commissioning policy on the use of extended half-life blood clotting factor products in people with haemophilia.

Answered on

14 October 2015

The Department plans to tender for extended half-life Clotting Factor VIII and Factor IX for use in the National Health Service once the products are granted European Union licences and are commercially available.

NHS England has made no decision at this time to whether it will develop a clinical commissioning policy for extended half-life productsbut, through the Clinical Reference Group and discussion with the Department’s Commercial Medicines Unit, will continue to review commissioning of these extended half-life products in the future.

Answered by

Department of Health and Social Care
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.